title: Response of metastatic breast cancer to trastuzumab?
authors.affiliation: ICRF Breast Pathology Laboratory and ICRF Breast Biology Group, Guy's Hospital, London, UK.
authors.forename: D M
authors.initials: DM
authors.lastname: Barnes
authors.forename: D W
authors.initials: DW
authors.lastname: Miles
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D000068878:Trastuzumab; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab